Key | % Net Assets |
---|---|
![]() |
4.4% |
![]() |
4.2% |
![]() |
4.1% |
![]() |
3.9% |
![]() |
83.4% |
Name | % Net Assets |
---|---|
BP | 4.4% |
HSBC | 4.2% |
Citigroup FRN 10/8/2011 | 4.1% |
Royal Bank of Scotland | 3.9% |
Barclays | 3.8% |
BT | 3.6% |
HBOS FRN 17/12/2009 | 3.3% |
New York Life FRN 8/9/2009 | 3.3% |
Santander Intnl Debt FRN 27/1/2011 | 3.2% |
GlaxoSmithKline | 2.9% |
No asset data available.
Date | 02-May-2025 |
---|---|
NAV | 293.11p |
Currency | GBP |
Change | 1.39p |
% | 0.48% |
YTD change | 9.18p |
YTD % | 3.23% |
Fund Inception | 31/10/2006 |
---|---|
Fund Manager | Michael Fraikin |
TER | 0.70 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research